questionsmedicales.fr
Eucaryotes
Viridiplantae
Streptophyta
Embryophyta
Tracheobionta
Magnoliopsida
Boraginaceae
Boraginaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Boraginaceae : Questions médicales les plus fréquentes",
"headline": "Boraginaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Boraginaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Boraginaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Magnoliopsida",
"url": "https://questionsmedicales.fr/mesh/D019684",
"about": {
"@type": "MedicalCondition",
"name": "Magnoliopsida",
"code": {
"@type": "MedicalCode",
"code": "D019684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amsinckia",
"alternateName": "Amsinckia",
"url": "https://questionsmedicales.fr/mesh/D029682",
"about": {
"@type": "MedicalCondition",
"name": "Amsinckia",
"code": {
"@type": "MedicalCode",
"code": "D029682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.122"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Borago",
"alternateName": "Borago",
"url": "https://questionsmedicales.fr/mesh/D029683",
"about": {
"@type": "MedicalCondition",
"name": "Borago",
"code": {
"@type": "MedicalCode",
"code": "D029683",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.188"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Consoude",
"alternateName": "Comfrey",
"url": "https://questionsmedicales.fr/mesh/D020844",
"about": {
"@type": "MedicalCondition",
"name": "Consoude",
"code": {
"@type": "MedicalCode",
"code": "D020844",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.210"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cordia",
"alternateName": "Cordia",
"url": "https://questionsmedicales.fr/mesh/D031213",
"about": {
"@type": "MedicalCondition",
"name": "Cordia",
"code": {
"@type": "MedicalCode",
"code": "D031213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.327"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Echium",
"alternateName": "Echium",
"url": "https://questionsmedicales.fr/mesh/D036661",
"about": {
"@type": "MedicalCondition",
"name": "Echium",
"code": {
"@type": "MedicalCode",
"code": "D036661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.385"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Eriodictyon",
"alternateName": "Eriodictyon",
"url": "https://questionsmedicales.fr/mesh/D031322",
"about": {
"@type": "MedicalCondition",
"name": "Eriodictyon",
"code": {
"@type": "MedicalCode",
"code": "D031322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.415"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Heliotropium",
"alternateName": "Heliotropium",
"url": "https://questionsmedicales.fr/mesh/D028162",
"about": {
"@type": "MedicalCondition",
"name": "Heliotropium",
"code": {
"@type": "MedicalCode",
"code": "D028162",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.444"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lithospermum",
"alternateName": "Lithospermum",
"url": "https://questionsmedicales.fr/mesh/D029684",
"about": {
"@type": "MedicalCondition",
"name": "Lithospermum",
"code": {
"@type": "MedicalCode",
"code": "D029684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.501"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pulmonaria",
"alternateName": "Pulmonaria",
"url": "https://questionsmedicales.fr/mesh/D029685",
"about": {
"@type": "MedicalCondition",
"name": "Pulmonaria",
"code": {
"@type": "MedicalCode",
"code": "D029685",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.875.800.575.912.250.150.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Boraginaceae",
"alternateName": "Boraginaceae",
"code": {
"@type": "MedicalCode",
"code": "D028082",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maryam Noroozi",
"url": "https://questionsmedicales.fr/author/Maryam%20Noroozi",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville, TN, 37996, USA."
}
},
{
"@type": "Person",
"name": "Farrokh Ghahremaninejad",
"url": "https://questionsmedicales.fr/author/Farrokh%20Ghahremaninejad",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran. fgh@khu.ac.ir."
}
},
{
"@type": "Person",
"name": "Mehrshid Riahi",
"url": "https://questionsmedicales.fr/author/Mehrshid%20Riahi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran."
}
},
{
"@type": "Person",
"name": "James I Cohen",
"url": "https://questionsmedicales.fr/author/James%20I%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Botany and Plant Ecology, Weber State University, 1415 Edvalson St., Dept. 2504, Ogden, UT, 84408, USA."
}
},
{
"@type": "Person",
"name": "José Luis Guil-Guerrero",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20Luis%20Guil-Guerrero",
"affiliation": {
"@type": "Organization",
"name": "Food Technology Division, University of Almería, 04120, Almería, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Novel neural network model for predicting susceptibility of facial post-inflammatory hyperpigmentation.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36064529",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.medengphy.2022.103884"
}
},
{
"@type": "ScholarlyArticle",
"name": "Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review.",
"datePublished": "2023-03-15",
"url": "https://questionsmedicales.fr/article/36924935",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaad.2023.02.053"
}
},
{
"@type": "ScholarlyArticle",
"name": "Atraric Acid Ameliorates Hyperpigmentation through the Downregulation of the PKA/CREB/MITF Signaling Pathway.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36555593",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232415952"
}
},
{
"@type": "ScholarlyArticle",
"name": "Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial.",
"datePublished": "2022-06-17",
"url": "https://questionsmedicales.fr/article/35737078",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/toxins14060417"
}
},
{
"@type": "ScholarlyArticle",
"name": "Higher incidence of neurotoxicity and skin hyperpigmentation in renal transplant patients treated with polymyxin B.",
"datePublished": "2022-05-29",
"url": "https://questionsmedicales.fr/article/35508710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bcp.15384"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Viridiplantae",
"item": "https://questionsmedicales.fr/mesh/D057948"
},
{
"@type": "ListItem",
"position": 4,
"name": "Streptophyta",
"item": "https://questionsmedicales.fr/mesh/D057949"
},
{
"@type": "ListItem",
"position": 5,
"name": "Embryophyta",
"item": "https://questionsmedicales.fr/mesh/D019669"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tracheobionta",
"item": "https://questionsmedicales.fr/mesh/D064028"
},
{
"@type": "ListItem",
"position": 7,
"name": "Magnoliopsida",
"item": "https://questionsmedicales.fr/mesh/D019684"
},
{
"@type": "ListItem",
"position": 8,
"name": "Boraginaceae",
"item": "https://questionsmedicales.fr/mesh/D028082"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Boraginaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Boraginaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Boraginaceae",
"description": "Comment identifier les plantes de la famille Boraginaceae ?\nQuels tests pour évaluer l'efficacité des Boraginaceae ?\nY a-t-il des critères spécifiques pour le diagnostic ?\nComment distinguer les Boraginaceae des autres familles ?\nQuels outils pour identifier les Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Hyperpigmentation&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Boraginaceae",
"description": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?\nLes Boraginaceae provoquent-elles des effets indésirables ?\nQuels symptômes d'intoxication peuvent survenir ?\nComment reconnaître une réaction allergique aux Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des troubles respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Hyperpigmentation&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Boraginaceae",
"description": "Comment éviter les effets indésirables des Boraginaceae ?\nQuelles précautions prendre avant d'utiliser des Boraginaceae ?\nLes Boraginaceae peuvent-elles interagir avec d'autres médicaments ?\nComment stocker les préparations à base de Boraginaceae ?\nY a-t-il des recommandations pour l'utilisation des Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Hyperpigmentation&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Boraginaceae",
"description": "Comment les Boraginaceae sont-elles utilisées en médecine ?\nQuels remèdes à base de Boraginaceae existent ?\nLes Boraginaceae sont-elles efficaces contre l'inflammation ?\nComment préparer un remède à base de Boraginaceae ?\nY a-t-il des contre-indications pour les traitements à base de Boraginaceae ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Hyperpigmentation&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Boraginaceae",
"description": "Quelles complications peuvent survenir avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles causer des problèmes hépatiques ?\nComment gérer une réaction allergique aux Boraginaceae ?\nY a-t-il des risques d'intoxication avec les Boraginaceae ?\nLes Boraginaceae peuvent-elles aggraver des maladies existantes ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Hyperpigmentation&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Boraginaceae",
"description": "Qui est à risque d'allergies aux Boraginaceae ?\nLes femmes enceintes doivent-elles éviter les Boraginaceae ?\nQuels facteurs augmentent le risque d'intoxication ?\nLes personnes âgées sont-elles plus vulnérables ?\nY a-t-il des risques pour les personnes atteintes de maladies chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D028082?mesh_terms=Hyperpigmentation&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les plantes de la famille Boraginaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les Boraginaceae se caractérisent par des fleurs en grappes et des feuilles alternées."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité des Boraginaceae ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études cliniques et des tests in vitro sont utilisés pour évaluer leur efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des critères spécifiques pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'identification botanique et l'analyse des propriétés médicinales."
}
},
{
"@type": "Question",
"name": "Comment distinguer les Boraginaceae des autres familles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation des caractéristiques florales et des feuilles aide à la distinction."
}
},
{
"@type": "Question",
"name": "Quels outils pour identifier les Boraginaceae ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des guides botaniques et des applications de reconnaissance de plantes sont utiles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à l'utilisation des Boraginaceae ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques, des troubles gastro-intestinaux ou des effets secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae provoquent-elles des effets indésirables ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines espèces peuvent causer des effets indésirables comme des nausées."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'intoxication peuvent survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des vomissements, des douleurs abdominales peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux Boraginaceae ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, éruptions cutanées ou œdème peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles causer des troubles respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles respiratoires peuvent survenir en cas d'allergie ou d'intoxication."
}
},
{
"@type": "Question",
"name": "Comment éviter les effets indésirables des Boraginaceae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de commencer par de faibles doses et de surveiller les réactions."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant d'utiliser des Boraginaceae ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé avant utilisation, surtout en cas de maladies préexistantes."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles interagir avec d'autres médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent interagir avec certains médicaments, il est donc important de vérifier."
}
},
{
"@type": "Question",
"name": "Comment stocker les préparations à base de Boraginaceae ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conserver dans un endroit frais et sec, à l'abri de la lumière pour préserver l'efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour l'utilisation des Boraginaceae ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les recommandations d'un professionnel de santé et respecter les dosages conseillés."
}
},
{
"@type": "Question",
"name": "Comment les Boraginaceae sont-elles utilisées en médecine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour traiter des inflammations, des douleurs et des troubles cutanés."
}
},
{
"@type": "Question",
"name": "Quels remèdes à base de Boraginaceae existent ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infusions, des pommades et des extraits sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae sont-elles efficaces contre l'inflammation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent qu'elles peuvent réduire l'inflammation et la douleur."
}
},
{
"@type": "Question",
"name": "Comment préparer un remède à base de Boraginaceae ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les feuilles peuvent être infusées ou utilisées en cataplasme pour des applications topiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des contre-indications pour les traitements à base de Boraginaceae ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes, comme les femmes enceintes, doivent éviter leur utilisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Boraginaceae ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des allergies sévères ou des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles causer des problèmes hépatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines espèces contiennent des composés toxiques pouvant affecter le foie."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux Boraginaceae ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser l'utilisation immédiatement et consulter un médecin si les symptômes persistent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'intoxication avec les Boraginaceae ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consommation excessive peut entraîner des symptômes d'intoxication."
}
},
{
"@type": "Question",
"name": "Les Boraginaceae peuvent-elles aggraver des maladies existantes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent aggraver certaines conditions, comme les maladies hépatiques ou rénales."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'allergies aux Boraginaceae ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies aux plantes sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter les Boraginaceae ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est recommandé qu'elles évitent leur utilisation en raison de risques potentiels."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'intoxication ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive ou l'utilisation de préparations non contrôlées augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être plus sensibles aux effets indésirables des Boraginaceae."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les personnes atteintes de maladies chroniques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladies chroniques doivent être prudentes avec leur utilisation."
}
}
]
}
]
}
To construct a neural network model (ATBP) for predicting susceptibility to Post-inflammatory hyperpigmentation (PIH), which is a rapid, objective, and reliable decision-support method before physical...
A dataset was established based on the VISIA Skin Analysis System detection results of 1953 patients with pigment disorders including 93,477 labeled data under 8 indicators. A novel Post-inflammatory ...
The results of comparison experiments indicate that Attentive BP (Back Propagation Neural Network) has a significant superiority in prediction accuracy (0.8604) compared with other machine learning mo...
Leveraging Multi-head self-attention mechanism and the architecture advantage of BPNN, the proposed model ATBP obtains the robust and efficient prediction performance in predicting PIH susceptibility ...
Acne vulgaris can be associated with hyperpigmentation, particularly in individuals with skin of color. This acne-induced macular hyperpigmentation (AMH), also called postinflammatory hyperpigmentatio...
Atraric acid (AA) is derived from lichens and is widely used in perfumes for its desirable scent. It has been reported as having anti-inflammatory and antioxidant activity. Hyperpigmentation is the un...
Incobotulinum toxin A (IncoBoNT-A) is effective in preventing ultraviolet B (UVB)-induced hyperpigmentation. This prospective, randomized, controlled study aimed to evaluate the effect of IncoBoNT-A o...
Toxicity is a major concern related to the clinical use of polymyxin B, and available safety data for renal transplant patients are limited....
We investigated the safety of polymyxin B and toxicity risk factors in renal transplant patients....
A prospective study was performed on a group of renal transplant patients who received intravenous polymyxin B between January 2018 and August 2021. Polymyxin B treatment was monitored to evaluate tox...
A total of 235 courses of polymyxin B were administered to 213 patients. Of these, 121 (51.5%) developed skin hyperpigmentation (SH), 149 (63.4%) developed neurotoxicity and 10 (5.5%) developed acute ...
Neurotoxicity and SH are the two major adverse effects of polymyxin B in renal transplant patients, which may limit its clinical use....
Localized scleroderma (LS) is characterized by skin fibrosis, hyperpigmentation and soft tissue atrophy. Fat grafting has been widely used to correct LS deformity....
To investigate the effect of fat grafting on the skin pigmentation of LS lesions....
A prospective self-controlled study was conducted. Skin melanin and erythema indexes were measured by Mexameter® MX18 before and 3 months after surgery. Differences between lesions and contralateral n...
Fourteen frontal linear LS patients participated in the study. Before surgery, the melanin index of the lesions was significantly higher than the contralateral sites (p = 0.023), while the erythema in...
Fat grafting could alleviate skin hyperpigmentation and skin damage of LS lesions while having little effect on skin erythema and disease activity....
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Inst...
Studies on facial hyperpigmentation across different facial units are limiting. We aimed to analyze melanin pigmentation images to observe facial pigmentary demarcation lines (FPDLs) and suggest facia...
3D facial melanin pigmentation images of 173 volunteers were obtained and analyzed for the presence of FPDLs. Pigmentation severity was assessed for each of the thirteen facial pigment units. The imag...
Four groups of FPDLs including a novel group I were observed. Nasal, frontal, auricular were the darkest pigmented facial pigment unit, and the anterior neck was the least pigmented. The dark spot typ...
Facial hyperpigmentation among healthy individuals with Fitzpatrick skin types II-IV is often accompanied by FPDLs and categorized into three types. Each type is modeled after the pattern of pigmentat...
Physiologic lip hyperpigmentation is a common aesthetic concern, especially in Southeast Asia. There is limited data on the application of the picosecond laser for this condition....
To evaluate the efficacy and safety of using a 755-nm picosecond laser in the treatment of physiologic lip hyperpigmentation....
Twenty healthy patients with physiologic lip hyperpigmentation received 5 bi-weekly treatments with a 755-nm picosecond laser using a 6-mm spot size, fluence of 0.71 J/cm 2 at 5 Hz. Subjective and obj...
All patients completed the study and attended all follow-ups. Most (52.6%) patients presented with moderate clinical improvement at 6-month follow-up. The average melanin index decreased significantly...
The 755-nm picosecond laser is safe and effective for the treatment of physiologic lip hyperpigmentation in Thai patients....
Topical application of tyrosinase inhibitors, such as hydroquinone and arbutin, is the most common clinical treatment for hyperpigmentation. Glabridin (Gla) is a natural isoflavone that inhibits tyros...
Tranexamic acid is used for the treatment of hyperpigmentation, and the topical route is the most favorable route for its administration. Tranexamic acid lowers plasmin and tyrosinase, which reduces m...
The mechanism of action of tranexamic acid and novel delivery systems for its topical delivery have been discussed. Further, patents related to the topical delivery of tranexamic acid and clinical tri...
Targeting tranexamic acid in the epidermal layer makes more amount of drug available for action on melanocytes, the target site for tranexamic acid. Novel drug delivery formulations like liposomes, so...